CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1999-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.19.5.1333PMID 10323787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ

  1998cited by this paper
• Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma.

  1998cited by this paper
• Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages.

  1998cited by this paper
• Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36*

  1997cited by this paper
• Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation.

  1996cited by this paper
• Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

  1995cited by this paper
• Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency.

  1995cited by this paper
• Molecular basis of CD36 deficiency : evidence that a [478]C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency

  1995cited by this paper
• Identification of molecular defects in a subject with type I CD36 deficiency.

  1994cited by this paper
• Platelet adhesion to collagen in individuals lacking glycoprotein IV.

  1994cited by this paper
• Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

  1994cited by this paper
• Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and ammo-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36.

  1993cited by this paper
• Red blood cell Na-Li countertransport, hypertensive heredity, and cardiovascular risk in young adults.

  1993cited by this paper
• Comparison of the In Vitro Fibrinolytic Activities of Low and High Molecular Weight Single-Chain Urokinase-Type Plasminogen Activator

  1993cited by this paper
• Presence of the entire coding region of GP IV mRNA in Nak(a)-negative platelets.

  1993cited by this paper
• Cellular mechanisms of atherogenesis.

  1993cited by this paper
• Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults.

  1993cited by this paper
• CD36 is a receptor for oxidized low density lipoprotein.

  1993cited by this paper
• A Novel Polymorphism in Glycoprotein IV (Replacement of Proline-90 by Serine) Predominates in Subjects with Platelet GPIV Deficiency

  1993cited by this paper
• Cloning of a Rat Adipocyte Membrane Protein Implicated in Binding or Transport of Long-chain Fatty Acids That Is Induced during Preadipocyte

  1993cited by this paper
• Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans.

  1992cited by this paper
• Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions.

  1992cited by this paper
• Expression of macrophage scavenger receptors in various human tissues and atherosclerotic lesions.

  1992cited by this paper
• Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine.

  1992cited by this paper
• Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

  1992cited by this paper
• Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils.

  1990cited by this paper
• Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.

  1990cited by this paper
• Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils

  1990cited by this paper
• Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions.

  1990cited by this paper
• A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein.

  1989cited by this paper
• Low density lipoprotein undergoes oxidative modification in vivo.

  1989cited by this paper
• Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

  1989cited by this paper
• A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.

  1989cited by this paper
• Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.

  1989cited by this paper
• Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Role of superoxide in endothelial-cell modification of low-density lipoproteins.

  1988cited by this paper
• Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions.

  1988cited by this paper
• Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

  1987cited by this paper
• Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

  1987cited by this paper
• Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.

  1986cited by this paper
• Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque

  1986cited by this paper
• Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor

  1986cited by this paper
• Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic

  1985cited by this paper
• Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells.

  1985cited by this paper
• Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation

  1984cited by this paper
• Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

  1984cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper

• A Western-Style Breakfast Induces a More Pro-Inflammatory Postprandial Response and Promotes Greater Macrophage Lipid Accumulation Compared to a Mediterranean-Style Breakfast in Obese and Normal-Weight Individuals.

  2026cites this paper
• Specific serotonin receptor antagonist reduces murine calcific atherosclerosis.

  2026cites this paper
• Phenotypic Shifts in Macrophages Within Advanced Atherosclerotic Plaques in Humans

  2025cites this paper
• γ‐Glutamylcysteine Inhibits VSMC‐Derived Foam Cell Formation via Upregulating Thioredoxin‐1 Expression

  2024cites this paper
• Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36

  2022cites this paper
• Fatty acid binding protein 3 deficiency limits atherosclerosis development via macrophage foam cell formation inhibition.

  2021cites this paper
• Oxidized LDLs as Signaling Molecules

  2021cites this paper
• Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.

  2021cites this paper
• miR-155–5p predictive role to decelerate foam cell atherosclerosis through CD36, VAV3, and SOCS1 pathway

  2021cites this paper
• Expression of ABC transporter and scavenger receptor mRNAs in PBMCs in 100‐km ultramarathon runners

  2020cites this paper
• CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation

  2020cites this paper
• Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE-/- mice

  2020cites this paper
• Astragalus avone ameliorates atherosclerosis and hepatic steatosis via improving lipid metabolism and inhibition of in ammation in apoE-/- mice

  2020cites this paper
• Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE−/− Mice

  2020cites this paper
• Atherogenic diet-induced bone loss is primarily due to increased osteoclastogenesis in mice.

  2020cites this paper
• Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice[S]

  2020cites this paper
• Nanoparticles target intimal macrophages in atherosclerotic lesions.

  2020cites this paper
• RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target

  2020cites this paper
• Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe

  2020cites this paper
• Nitro-oleic acid, a ligand of CD36, reduces cholesterol accumulation by modulating oxidized-LDL uptake and cholesterol efflux in RAW264.7 macrophages

  2020cites this paper
• Elevated Neuropeptide Y in Endothelial Dysfunction Promotes Macrophage Infiltration and Smooth Muscle Foam Cell Formation

  2019influential citation
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors

  2019cites this paper
• CD36 and lipid metabolism in the evolution of atherosclerosis

  2018cites this paper
• Molecular Response of Retinal Pigment Epithelial Cells to Oxidized Lipoproteins: Global and Targeted Studies

  2018cites this paper
• The CD36-PPARγ Pathway in Metabolic Disorders

  2018cites this paper
• A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis

  2018cites this paper
• Effect of 7,8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages.

  2017cites this paper
• Estudo dos efeitos de duas fosfolipases A2 (MT-III e BthTx-II) isoladas do venenos de serpentes Bothrops em células de músculo liso vascular em cultura: formação de corpúsculos lipídicos e mecanismos envolvidos.

  2017cites this paper
• Platelets and Diabetes

  2017cites this paper
• The role of CD36 receptor in the pathogenesis of atherosclerosis.

  2017cites this paper
• Les effets anti-angiogéniques des microparticules dérivées des lymphocytes T sur la néovascularisation choroïdienne

  2017cites this paper
• CD 36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages

  2017cites this paper
• A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics

  2017cites this paper
• Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization

  2016cites this paper
• Oxidized Lipoprotein Uptake Through the CD36 Receptor Activates the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells

  2016cites this paper
• Stress oxydant et pathologie diabétique : impact de l'hyperglycémie et de l'albumine glyquée sur les cellules cardiaques et adipeuses

  2016cites this paper
• VISFATIN PROMOTES FOAM CELL FORMATION BY DYSREGULATING CD36, SRA, ABCA1, AND ABCG1 EXPRESSION IN RAW264.7 MACROPHAGES

  2015cites this paper
• Platelets and diabetes mellitus.

  2015cites this paper
• Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration

  2015cites this paper
• Lipids in health and disease

  2014cites this paper
• The impact of dietary fatty acids on macrophage cholesterol homeostasis.

  2014cites this paper
• Residual Risk and Biology of the Disease: Implications for Plaque Imaging

  2014cites this paper
• Role of advanced glycation end products in cellular signaling

  2014cites this paper
• Characterization of transglutaminase 2 in macrophage clearance of apoptotic cells

  2013cites this paper
• Fatty acids, monocytes and ageing

  2013cites this paper
• Mechanisms of 7,8-dihydroneopterin protection of macrophages from cytotoxicity

  2013cites this paper
• Charakterisierung von CXCL16/SR-PSOX als neuer Scavenger-Rezeptor auf Thrombozyten

  2013cites this paper
• Receptor Pathway and Enhanced by Hypoxic Conditions Lipid Accumulation in Smooth Muscle Cells Under LDL Loading Is Independent of LDL

  2013cites this paper
• Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis

  2013cites this paper
• Endoplasmic Reticulum Stress Promotes Macrophage-derived Foam Cell Formation by Up-regulating Cluster of Differentiation 36 (CD36) Expression*

  2013cites this paper
• Paper de la proteïna scavenger AIM en l’activació de macròfags i desenvolupament de cèl·lules escumoses

  2013cites this paper
• Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis

  2012cites this paper
• Régulation du métabolisme et du transport des lipides dans les macrophages : potentiel anti-athérosclérotique des ligands du CD36

  2012cites this paper
• Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.

  2012cites this paper
• EGF receptor (ERBB1) abundance in adipose tissue is reduced in insulin-resistant and type 2 diabetic women.

  2012cites this paper
• Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages.

  2011cites this paper
• The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus.

  2011cites this paper
• Thiazolidinedione‐independent activation of peroxisome proliferator‐activated receptor γ is a potential target for diabetic macrovascular complications

  2011cites this paper
• Molecular cloning and functional analysis of scavenger receptor zebrafish CL-P1.

  2011cites this paper
• Studies on Scavenger Receptors under Experimental Hypercholesterolemia: Modulation on Selenium Supplementation

  2011cites this paper
• Aged garlic extract inhibits CD36 expression in human macrophages via modulation of the PPARγ pathway

  2010cites this paper
• Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors.

  2010cites this paper
• Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids.

  2010cites this paper
• Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model.

  2010cites this paper
• Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat.

  2010cites this paper
• Nobiletin metabolite, 3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells.

  2010cites this paper
• The inflammatory response in extravasated leukocytes in patients with coronary artery disease

  2010cites this paper
• An Imbalance Between CD36 and ABCA1 Protein Expression Favors Lipid Accumulation in Stroke-Prone Ulcerated Carotid Plaques

  2010cites this paper
• Chapitre 1 – Données Anatomopathologiques en Pathologie Vasculaire: L'athérosclérose

  2010cites this paper
• In vivo Extravasated Human Monocytes have an Altered Expression of CD16, HLA‐DR, CD86, CD36 and CX3CR1

  2009cites this paper
• Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

  2009cites this paper
• A BRIEF COMMUNICATION

  2009cites this paper
• Macrophage-Specific Lipid-Based Nanoparticles Improve MRI Detection and Characterization of Human Atherosclerosis

  2009cites this paper
• Rosetting and the innate immune response to plasmodium falciparum

  2009cites this paper
• CCL 18 and CXCL 16: traffic control in rheumatoid arthritis.

  2009cites this paper
• Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages.

  2009cites this paper
• Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production.

  2009cites this paper
• Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.

  2009cites this paper
• Dialysis-related systemic microinflammation is associated with specific genomic patterns.

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Hexarelin Signaling to PPARγ in Metabolic Diseases

  2008cites this paper
• Nε-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status

  2008cites this paper
• Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements.

  2008cites this paper
• CD36 Is Significantly Correlated with Adipophilin in Human Carotid Lesions and Inversely Correlated with Plasma ApoAI

  2008cites this paper
• Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.

  2008cites this paper
• Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability

  2008cites this paper
• CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro.

  2008cites this paper
• [Receptor CD36 expression on peripheral blood monocytes in women with visceral obesity].

  2008cites this paper
• Estudio farmacogenómico mediante microarrays en monocitos de pacientes con hiperlipemia familiar combinada tratados con atorvastatina

  2008cites this paper
• Lipids in Health and Disease Lipoprotein Binding Preference of Cd36 Is Altered by Filipin Treatment

  2008cites this paper
• Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages.

  2008cites this paper
• Etude des effets de la protéine C-réactive sur certains aspects de la biologie des cellules mononucléées circulantes et des monocytes humains : Implications pour la physiopathologie des maladies cardiovasculaires

  2008cites this paper
• Molecular Basis of Human CD36 Gene Mutations

  2007cites this paper
• ResponseAssociated with a Differential Inflammatory Oxidized Low-Density Lipoprotein Is Expression in Human Macrophages with Individual Variation of Scavenger Receptor

  2007cites this paper
• Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes

  2007cites this paper
• Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients

  2007cites this paper
• Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells.

  2007cites this paper
• Effects of Soy Pinitol on the Pro-Inflammatory Cytokines and Scavenger Receptors in Oxidized Low-Density Lipoprotein-Treated THP-1 Macrophages

  2007cites this paper
• Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention.

  2007cites this paper